title: Effects of immunizing ewes against bone morphogenetic protein 15 on their responses to exogenous gonadotrophins to induce multiple ovulations.
abstract: Sheep with a heterozygous inactivating mutation in the bone morphogenetic protein 15 (BMP15) gene experience an increased ovulation rate during either a natural oestrous cycle or a cycle in which exogenous FSH and eCG (gonadotrophins) are given to induce multiple ovulations. The primary aim of these studies was to determine whether ewes immunised against BMP15 would also show an improved superovulation rate following exogenous gonadotrophin treatment. A secondary aim was to determine the effects of BMP15 immunisation on ovarian follicular characteristics. In most ewes (i.e. > 75%) immunised with a BMP15-keyhole limpet haemocyanin peptide in an oil-based adjuvant in order to completely neutralise BMP15 bioactivity, there was no superovulation response to exogenous gonadotrophins. In ewes treated with exogenous gonadotrophins following a BMP15-BSA peptide immunisation in a water-based adjuvant to partially neutralise BMP15 bioactivity, the ovulation rate response was similar to the control superovulation treatment groups. Characterisation of follicular function revealed that the water-based BMP15-immunised animals had fewer non-atretic follicles 2.5-3.5 or > 4.5  mm in diameter compared with controls. Basal concentrations of cAMP were higher in granulosa cells from animals immunised against BMP15 than control animals. There were no significant differences in the concentrations of cAMP between granulosa cells from BMP15- and control-immunised animals when given FSH or hCG, although there were differences in the proportions of follicles in different size classes that responded to FSH or hCG. Thus, immunisation against BMP15 may have been causing premature luteinisation and thereby limiting the numbers of follicles recruited for ovulation following treatment with exogenous gonadotrophins.
authors.affiliation: Centre for Reproduction and Genomics, AgResearch Limited, Invermay Animal Research Centre, Puddle Alley, Private Bag 50034, Mosgiel 9053, New Zealand. jenny.juengel@agresearch.co.nz
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Juengel
authors.forename: Laurel D
authors.initials: LD
authors.lastname: Quirke
authors.forename: Stan
authors.initials: S
authors.lastname: Lun
authors.forename: Derek A
authors.initials: DA
authors.lastname: Heath
authors.forename: Peter D
authors.initials: PD
authors.lastname: Johnstone
authors.forename: Kenneth P
authors.initials: KP
authors.lastname: McNatty
mesh_terms: D000818:Animals; D000906:Antibodies / Q000097:blood; D055430:Bone Morphogenetic Protein 15 / Q000276:immunology*; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D006062:Gonadotropins / Q000494:pharmacology*; D006433:Hemocyanins / Q000494:pharmacology; D007114:Immunization / Q000379:methods; D023421:Models, Animal; D006080:Ovarian Follicle / Q000187:drug effects / Q000378:metabolism; D010062:Ovulation Induction / Q000379:methods*; D012756:Sheep / Q000502:physiology*; D013480:Superovulation / Q000187:drug effects* / Q000502:physiology
chemical_list: D000906:Antibodies; D055430:Bone Morphogenetic Protein 15; D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D005640:Follicle Stimulating Hormone; D006433:Hemocyanins; D000242:Cyclic AMP